|
|
Article: Sir Richard Sykes, Former Glaxo Wellcome Chairman, CEO and GlaxoSmithKline Chairman, Agrees to Join the Abraxis BioScience Board of Directors.
- Article from:
- PR Newswire
- Article date:
- December 20, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SCHAUMBURG, Ill. and SANTA MONICA, Calif., Dec. 20 /PRNewswire-FirstCall/ -- American Pharmaceutical Partners, Inc. (APP), and American BioScience, Inc. (ABI) today announced that Sir Richard Sykes, former Chairman and Chief Executive Officer of Glaxo Wellcome plc and Chairman of the Board of GlaxoSmithKline plc, has agreed to join the Board of Directors of Abraxis BioScience, Inc. following the consummation of the proposed merger between APP and ABI (APP will be renamed Abraxis BioScience following the merger). Sir Richard currently serves as Rector of the largest applied science and technology university in the United Kingdom, the Imperial College of Science, ...
Related newspaper, magazine, and journal articles:
|
|
Article: Abraxis BioScience Names Lonnie Moulder President ...
Business Wire;
April 30, 2009 ;
700+ words
... ... Abraxis Health -- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABII), a fully ... positions of Chairman and CEO of Abraxis BioScience since founding the company, will ... growth." "It is an honor to lead Abraxis BioScience at such a pivotal time in the company ...
|
|